

Cover Story
Regulatory News
By Jacquelyn Cobb and Paul Goldberg
Can a single drug replace a long-established curative, albeit brutal, regimen of chemotherapy, radiation, and surgery?
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
Trending Stories
- House passes three-year extension of ACA subsidies with bipartisan support
- Nancy Goodman: “Sen. Sanders says he cares about kids with cancer. I’m just asking him to show us.”
- A planned randomized trial will ask an intriguing question: Do COVID vaccines potentiate checkpoint inhibitors?
- NIH agrees to review hundreds of denied or shelved grant applications
- Gregory Curt, Clinician and Drug Developer, Dies at 64
- Elisa Rodriguez named first chief diversity and equity officer for faculty at Roswell Park

















